Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23228
Full metadata record
DC FieldValueLanguage
dc.contributor.authorO'Connor, Ellen-
dc.contributor.authorTeh, Jiasian-
dc.contributor.authorKamat, Ashish M-
dc.contributor.authorLawrentschuk, Nathan-
dc.date2020-05-14-
dc.date.accessioned2020-05-18T06:53:42Z-
dc.date.available2020-05-18T06:53:42Z-
dc.date.issued2020-07-
dc.identifier.citationFuture oncology (London, England) 2020; 16(19): 1323-1325-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/23228-
dc.language.isoeng-
dc.subjectBCG vaccine-
dc.subjectCOVID-19-
dc.subjectclinical trials-
dc.subjectcoronavirus-
dc.subjectimmunotherapy-
dc.subjectmycobacterium bovis-
dc.titleBacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?-
dc.typeJournal Article-
dc.identifier.journaltitleFuture oncology (London, England)-
dc.identifier.affiliationDepartment of Urology, The Royal Melbourne Hospital, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDivision of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA-
dc.identifier.doi10.2217/fon-2020-0381-
dc.identifier.orcid0000-0001-8553-5618en
dc.identifier.orcid0000-0001-8576-586Xen
dc.identifier.orcid0000-0002-7882-5155en
dc.identifier.pubmedid32406253-
dc.type.austinEditorial-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Jan 18, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.